Patients with VITT have high levels of antibodies to platelet factor 4 (PF4)–polyanion complexes [2] with platelet activating ability, and the mechanism of thrombosis and bleeding resembles that of autoimmune heparin-induced thrombocytopenia [3]. This evidence concerns the gene PF4 and Thrombocytopenia.